These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6102813)

  • 41. beta-blockade, atrial natriuretic peptide and exercise.
    Kantola I; Tarssanen L; Scheinin M; Ruskoaho H; Viinamäki O; Kaila T
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):12-6. PubMed ID: 8688991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of atenolol and propranolol on human performance and subjective feelings.
    Landauer AA; Pocock DA; Prott FW
    Psychopharmacology (Berl); 1979 Jan; 60(2):211-5. PubMed ID: 106432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of circulatory responsiveness following the sudden withdrawal from atenolol and propranolol.
    Schwartz J; Jackson G; Kates RE; Harrison DC
    Eur Heart J; 1981 Feb; 2(1):31-9. PubMed ID: 7274264
    [No Abstract]   [Full Text] [Related]  

  • 44. The psychomotor effects of atenolol and other antihypertensive agents.
    Clayton AB; Harvey PG; Betts TA
    Postgrad Med J; 1977; 53 Suppl 3():157-61. PubMed ID: 337269
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of atenolol on exercise haemodynamics in angina pectoris and hypertension (abstract).
    Aström H; Vallin H
    Postgrad Med J; 1977; 53 Suppl 3():84. PubMed ID: 928272
    [No Abstract]   [Full Text] [Related]  

  • 46. Both atenolol and propranolol blunt the fibrinolytic response to exercise but not resting fibrinolytic potential.
    Fernhall B; Szymanski LM; Gorman PA; Kamimori GH; Kessler CM
    Am J Cardiol; 2000 Dec; 86(12):1398-400, A6. PubMed ID: 11113426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 48. Selective and non-selective beta-adrenoreceptor blockade in the human forearm.
    Hartling OJ; Noer I; Svendsen TL; Clausen JP; Trap-Jensen J
    Clin Sci (Lond); 1980 Apr; 58(4):279-86. PubMed ID: 7379453
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.
    Graham BR; Littlejohns DW; Prichard BN; Scales B; Southorn P
    Br J Pharmacol; 1973 Sep; 49(1):154P-155P. PubMed ID: 4150762
    [No Abstract]   [Full Text] [Related]  

  • 50. beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing.
    Romana-Souza B; Santos JS; Monte-Alto-Costa A
    Wound Repair Regen; 2009; 17(2):230-9. PubMed ID: 19320892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proceedings: Effect of selective and non-selective beta-blockade on coronary circulation in man.
    Stephens J; Hamer J; Hayward R; Ead H
    Br Heart J; 1976 Mar; 38(3):313-4. PubMed ID: 1259858
    [No Abstract]   [Full Text] [Related]  

  • 52. A multidimensional concept for measuring CNS effects of beta-adrenoceptor blocking agents in human pharmacology.
    Wagner W; Ott H; Herrmann WM; McDonald RJ; Berzewski B
    Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):23-33. PubMed ID: 6110635
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiovascular responses to beta-blockade and 5 degrees C cold air stress.
    Headley SA; Moser CD; Golan R; Kendrick ZV; Finck A; Paolone AM
    Can J Physiol Pharmacol; 1996 Jan; 74(1):112-5. PubMed ID: 8963946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].
    Regula H; Papner B
    Arzneimittelforschung; 1974 Sep; 24(9):1328-30. PubMed ID: 4154767
    [No Abstract]   [Full Text] [Related]  

  • 55. [Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
    Greminger P; Vetter H; Boerlin HJ; Baumgart P; Havelka J; Walger P; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1982 Dec; 112(50):1831-5. PubMed ID: 7156966
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of propranolol on verbal problem solving in autism spectrum disorder.
    Beversdorf DQ; Carpenter AL; Miller RF; Cios JS; Hillier A
    Neurocase; 2008; 14(4):378-83. PubMed ID: 18766980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of abrupt withdrawal of chronically administered beta-blocking drugs on cardiac sensitivity in the rat.
    Botting JH; Crook P
    Experientia; 1981 Dec; 37(12):1320-2. PubMed ID: 6120090
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
    Stensrud P; Sjaastad O
    Headache; 1980 Jul; 20(4):204-7. PubMed ID: 6993420
    [No Abstract]   [Full Text] [Related]  

  • 59. Proceedings: The hypoglycaemic action of ICI 66082 (4-(2-hydroxy-3-isopropyl-aminopropoxy) phenyl acetamide) in the rat.
    Furman BL; Tayo FM
    Br J Pharmacol; 1974 Sep; 52(1):143P. PubMed ID: 4155984
    [No Abstract]   [Full Text] [Related]  

  • 60. [Demonstration in healthy volunteers of the partial agonist effect of a cardioselective beta-blocker, cicloprolol].
    Grilliat JP; Le Van D; Mayeux D; Régnier F; Thiercelin JF; Thenot JP; Orofiamma B; Larribaud J
    Therapie; 1987; 42(6):519-24. PubMed ID: 2894724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.